QIAGEN Proposes Annual Cash Dividend to Shareholders

QIAGEN N.V. has announced its intention to propose the initiation of an annual cash dividend for shareholder approval at its upcoming Annual General Meeting set for June 26, 2025. The decision aligns with QIAGEN's strategy to enhance shareholder returns while maintaining reinvestment flexibility for long-term growth.

The proposed initial dividend payment is $0.25 per ordinary share, equating to approximately $54 million in total payout. The Supervisory Board's decision remains subject to shareholder approval, with planned key dates including a record date on July 2, 2025, and a payment date on July 10, 2025.

This move underlines QIAGEN’s commitment to balancing capital returns with sustainable growth, evaluating factors such as available profits, investments, and mergers and acquisitions opportunities under its revised dividend policy.